RxDoctor Payments Data

Wael Ghali, MD

Hospitalist · Evanston, ILNPI 1467518118

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 109 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Johnson & Johnson at 34.2% of the total. Reporting peaked in 2022 at $1,257 and has fallen 68.0% since, to $402 in 2025. Among hospitalist clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,594in general payments, 2019–2025

Across 109 payments — averaging $42.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$2K
  • AstraZeneca$888
  • Janssen Scientific Affairs, LLC$651
  • Mallinckrodt Hospital Products Inc.$283
  • Novartis$258
  • AbbVie$232
  • plus $710 from 8 others

What the payments were for

  • Food & beverage$4,594100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,594 in reported general payments places this provider in the 95th percentile of 1,328 hospitalist providers in Illinois.

See all hospitalist providers in Illinois

Medicare billing

Part B allowed, 2024
$149,444
Medicare patients
509
Services billed
1,228

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban18$11,674
Pantoprazole Sodium34$679
Sucralfate13$582
Losartan Potassium37$311
Metoprolol Succinate26$261
Amlodipine Besylate34$230
Mirtazapine12$226
Atorvastatin Calcium16$220
Isosorbide Mononitrate ErIsosorbide Mononitrate12$107
Furosemide15$80
ClopidogrelClopidogrel Bisulfate12$54
Levofloxacin12$34
Tamsulosin Hcl12$32
Prednisone16$21

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$131$11,67418 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,328 hospitalist providers in Illinois.

Other hospitalist in Evanston

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →